Dutch Tariff for the Five-Level Version of EQ-5D
Open accessAbstract
BACKGROUND: In 2009, a new version of the EuroQol five-dimensional questionnaire (EQ-5D) was introduced with five rather than three answer levels per dimension. This instrument is known as the EQ-5D-5L. To make the EQ-5D-5L suitable for use in economic evaluations, societal values need to be attached to all 3125 health states. OBJECTIVES: To derive a Dutch tariff for the EQ-5D-5L. METHODS: Health state values were elicited during face-to-face interviews in a general population sample stratified for age, sex, and education, using composite time trade-off (cTTO) and a discrete choice experiment (DCE). Data were modeled using ordinary least squares and tobit regression (for cTTO) and a multinomial conditional logit model (for DCE). Model performance was evaluated on the basis of internal consistency, parsimony, goodness of fit, handling of left-censored values, and theoretical considerations. RESULTS: A representative sample (N = 1003) of the Dutch population participated in the valuation study. Data of 979 and 992 respondents were included in the analysis of the cTTO and the DCE, respectively. The cTTO data were left-censored at -1. The tobit model was considered the preferred model for the tariff on the basis of its handling of the censored nature of the data, which was confirmed through comparison with the DCE data. The predicted values for the EQ-5D-5L ranged from -0.446 to 1. CONCLUSIONS: This study established a Dutch tariff for the EQ-5D-5L on the basis of cTTO. The values represent the preferences of the Dutch population. The tariff can be used to estimate the impact of health care interventions on quality of life, for example, in context of economic evaluations.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The EuroQol-5D-5L is a generic instrument for measuring health-related quality of life in cancer patients.
“To measure health related quality of life of cancer patients, we will use the EuroQol-5D-5L (EQ-5D) [29].”
The youth version of the EQ-5D-5L was designed to be used in adolescents up to age 15 years.
“The adult version of the EQ-5D-5L will be used to consistently assess the quality of life during the study, as the youth version of this questionnaire was designed to be used in adolescents up to age 15 years [58].”
From The (cost-)effectiveness of early intervention (MBT-early) versus standard protocolized treatment (CBT) for emerging borderline personality disorder in adolescents (the EARLY study): a study protocol for a randomized controlled trial (2024) · cites this paper as [58]
The Introduction (page unavailable) describes the EQ-5D-5L, and the Respondents section (page unavailable) describes a valuation sample restricted to adults aged 18 or older. Neither addresses a youth version or an upper age limit of 15; searches for the youth version, adolescents, and EQ-5D-Y found no passage establishing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795 · cited 3× · see citing works
“improvement over the previous EQ-5D [1,6,7].”
BackgroundMethod(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544 · see citing works
Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., Swinburn, P., & Busschbach, J. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0322-4 · Cited by 1,582 · see citing works
US Valuation of the EQ-5D Health States
Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005) · Medical Care · doi:10.1097/00005650-200503000-00003 · Cited by 1,271 · see citing works
Measuring and Valuing Health Benefits for Economic Evaluation
Brazier, J. E., Ratcliffe, J., Salomon, J. A., & Tsuchiya, A. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780198725923.001.0001 · Cited by 1,051 · see citing works
A comparison of the EQ‐5D and SF‐6D across seven patient groups
Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004) · Health Economics · doi:10.1002/hec.866 · Cited by 797 · see citing works
The Dutch tariff: results and arguments for an effective design for national EQ‐5D valuation studies
Lamers, L. M., McDonnell, J., Stalmeier, P. F. M., Krabbe, P. F. M., & Busschbach, J. J. V. (2006) · Health Economics · doi:10.1002/hec.1124 · Cited by 625 · see citing works
A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol
Oppe, M., Devlin, N. J., van Hout, B., Krabbe, P. F. M., & de Charro, F. (2014) · Value in Health · doi:10.1016/j.jval.2014.04.002 · Cited by 431 · see citing works
Comparing the Standard EQ-5D Three-Level System with a Five-Level Version
Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00230.x · Cited by 275 · see citing works
The development of new research methods for the valuation of EQ-5D-5L
Devlin, N. J., & Krabbe, P. F. M. (2013) · The European Journal of Health Economics · doi:10.1007/s10198-013-0502-3 · Cited by 262 · see citing works
Psychometric Comparison of the Standard EQ-5D to a 5 Level Version in Cancer Patients
Pickard, A. S., De Leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007) · Medical Care · doi:10.1097/01.mlr.0000254515.63841.81 · Cited by 259 · see citing works
Bharmal, M. F., & Thomas, J. (2006) · Value in Health · doi:10.1111/j.1524-4733.2006.00108.x · Cited by 179 · see citing works
Time trade-off: one methodology, different methods
Attema, A. E., Edelaar-Peeters, Y., Versteegh, M., et al. (2013) · The European Journal of Health Economics · doi:10.1007/s10198-013-0508-x · Cited by 158 · see citing works
Introducing the composite time trade-off: a test of feasibility and face validity
Janssen, B., Oppe, M., Versteegh, M., & Stolk, E. A. (2013) · The European Journal of Health Economics · doi:10.1007/s10198-013-0503-2 · Cited by 151 · see citing works
Discrete Choice Modeling for the Quantification of Health States: The Case of the EQ-5D
Stolk, E. A., Oppe, M., Scalone, L., & Krabbe, P. F. M. (2010) · Value in Health · doi:10.1111/j.1524-4733.2010.00783.x · Cited by 121 · see citing works
Condition-Specific Preference-Based Measures: Benefit or Burden?
Versteegh, M., Leunis, A., Groot, C. A. U., & Stolk, E. A. (2012) · Value in Health · doi:10.1016/j.jval.2011.12.003 · Cited by 111 · see citing works
Knies, S., Evers, S., Candel, M. J. J. M., Severens, J. L., & Ament, A. J. H. A. (2009) · PharmacoEconomics · doi:10.2165/11314120-000000000-00000 · Cited by 102 · see citing works
Janssen, M. F., Birnie, E., & Bonsel, G. J. (2008) · Quality of Life Research · doi:10.1007/s11136-008-9318-5 · Cited by 84 · see citing works
Protocols for Time Tradeoff Valuations of Health States Worse than Dead: A Literature Review
Tilling, C., Devlin, N. J., Tsuchiya, A., & Buckingham, K. (2010) · Medical Decision Making · doi:10.1177/0272989x09357475 · Cited by 69 · see citing works
Pickard, A. S., Kohlmann, T., Janssen, M. F., Bonsel, G., Rosenbloom, S., & Cella, D. (2007) · Medical Care · doi:10.1097/mlr.0b013e31805371aa · Cited by 66 · see citing works
Krabbe, P. F. M., Devlin, N. J., Stolk, E. A., et al. (2014) · Medical Care · doi:10.1097/mlr.0000000000000178 · Cited by 45 · see citing works
Lead versus lag-time trade-off variants: does it make any difference?
Augustovski, F., Rey‐Ares, L., Irazola, V. E., et al. (2013) · The European Journal of Health Economics · doi:10.1007/s10198-013-0505-0 · Cited by 37 · see citing works
Time to tweak the TTO: results from a comparison of alternative specifications of the TTO
Versteegh, M., Attema, A. E., Oppe, M., et al. (2013) · The European Journal of Health Economics · doi:10.1007/s10198-013-0507-y · Cited by 33 · see citing works
Ramos-Goñi, J. M., Rivero‐Arias, O., Rodríguez, M. E., et al. (2013) · The European Journal of Health Economics · doi:10.1007/s10198-013-0511-2 · Cited by 33 · see citing works
Shah, K. K., Lloyd, A. J., Oppe, M., & Devlin, N. J. (2013) · The European Journal of Health Economics · doi:10.1007/s10198-013-0509-9 · Cited by 28 · see citing works
The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework
Luo, N., Li, M., Stolk, E. A., et al. (2013) · The European Journal of Health Economics · doi:10.1007/s10198-013-0504-1 · Cited by 26 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Oppe M, van Hout B. The optimal hybrid: experimental design and modeling of a combination of TTO and DCE. Presented at: 27th Scientific Plenary Meeting of the EuroQol Group-Proceedings. EuroQol Group Executive Office, Rotterdam, the Netherlands, 2010: [Accessed June 11, 2015].
- Dolan P. Modeling valuations for the EuroQol health states. Med Care 1997;35:1095-108.
- Bonsel GJ, Oppe M, Janssen MF. Unexpected large misspecification effects of health profile selection and interaction analysis to obtain a value function from unsaturated valuation datasets, using the standard EuroQol approach. Presented at: EuroQoL Proceedings Plenary Meeting. Stockholm, Sweden, September 25-26, 2014.
Cited by
Sorted by citations
Valuing health-related quality of life: an EQ-5D-5L value set for England
Devlin, N. J., Shah, K. K., Feng, Y., Mulhern, B., & van Hout, B. (2018) · Health Economics · doi:10.1002/hec.3564 · Cited by 1,356 · see citing works
Stolk, E., Ludwig, K., Rand, K., van Hout, B., & Ramos-Goñi, J. M. (2019) · Value in Health · doi:10.1016/j.jval.2018.05.010 · Cited by 362 · see citing works
Self-citationBels, J. L. M., Thiessen, S., van Gassel, R. J. J., Beishuizen, A., De Bie Dekker, A., Fraipont, V., Lamote, S., Ledoux, D., Scheeren, C., De Waele, E., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01304-7 · Cited by 174 · see citing works
Weerts, Z. Z. R. M., Masclee, A. A. M., Witteman, B. J. M., Clemens, C. H. M., Winkens, B., Brouwers, J. R. B. J., Frijlink, H. W., Muris, J. W. M., De Wit, N. J., Essers, B. A. B., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.08.026 · Cited by 137 · see citing works
Vlake, J. H., van Bommel, J., Wils, E.-J., Bienvenu, J., Hellemons, M. E., Korevaar, T. I., Schut, A. F., Labout, J. A., Schreuder, L. L., van Bavel, M. P., et al. (2022) · Journal of Medical Internet Research · doi:10.2196/32368 · Cited by 84 · see citing works
Hernández-Alava, M., & Pudney, S. (2017) · Journal of Health Economics · doi:10.1016/j.jhealeco.2017.06.013 · Cited by 64 · see citing works
Romijn, G., Batelaan, N., Koning, J., van Balkom, A., de Leeuw, A., Benning, F., Hakkaart van Roijen, L., & Riper, H. (2021) · PLOS ONE · doi:10.1371/journal.pone.0259493 · Cited by 46 · see citing works
“We applied the Dutch tariff [48] to calculate the utilities.”
Vlake, J. H., Van Bommel, J., Wils, E.-J., Korevaar, T. I. M., Bienvenu, O. J., Klijn, E., Gommers, D., & van Genderen, M. E. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000538 · Cited by 41 · see citing works
Witlox, M., Kraaij, V., Garnefski, N., Bohlmeijer, E., Smit, F., & Spinhoven, P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262220 · Cited by 31 · see citing works
Bolinski, F., Kleiboer, A., Karyotaki, E., Bosmans, J. E., Zarski, A.-C., Weisel, K. K., Ebert, D. D., Jacobi, C., Cuijpers, P., & Riper, H. (2018) · Trials · doi:10.1186/s13063-018-2477-y · Cited by 31 · see citing works
Leijdesdorff, S. M. J., Huijs, C. E. M., Klaassen, R. M. C., Popma, A., van Amelsvoort, T. A. M. J., & Evers, S. M. A. A. (2023) · Journal of Mental Health · doi:10.1080/09638237.2020.1836555 · Cited by 20 · see citing works
Self-citationWitlox, M., Kraaij, V., Garnefski, N., de Waal, M. W. M., Smit, F., Hoencamp, E., Gussekloo, J., Bohlmeijer, E. T., & Spinhoven, P. (2018) · Trials · doi:10.1186/s13063-018-2731-3 · Cited by 23 · see citing works
Boonstra, A., van Mastrigt, G. A. P. G., Evers, S. M. A. A., van Amelsvoort, T. A. M. J., Leijdesdorff, S. M. J., & @ease consortium (2023) · Early Intervention in Psychiatry · doi:10.1111/eip.13443 · Cited by 18 · see citing works
Self-citationGroot, I. Z., Venhuizen, A.-S. S. M., Bachrach, N., Walhout, S., de Moor, B., Nikkels, K., Dalmeijer, S., Maarschalkerweerd, M., van Aalderen, J. R., de Lange, H., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04248-9 · Cited by 18 · see citing works
Self-citationvan Beek, F. E., Wijnhoven, L. M. A., Jansen, F., Custers, J. A. E., Aukema, E. J., Coupé, V. M. H., Cuijpers, P., van der Lee, M. L., Lissenberg-Witte, B. I., Wijnen, B., et al. (2019) · BMC Psychology · doi:10.1186/s40359-019-0368-y · Cited by 13 · see citing works
Health state utilities for infertility and subfertility
Krol, M., Nap, A., Michels, R., Veraart, C., & Goossens, L. (2019) · Reproductive Health · doi:10.1186/s12978-019-0706-9 · Cited by 12 · see citing works
Badaghi, N., van Kruijsbergen, M., Prins, J., Kelders, S., Cillessen, L., Compen, F., Donders, R., Kwakkenbos, L., & Speckens, A. (2023) · BMC Psychology · doi:10.1186/s40359-023-01052-2 · Cited by 8 · see citing works
“Dutch tariff for the five-level version of EQ-5D.”
MethodInfluentialDaniëls, M., Van, H. L., van den Heuvel, B., Dekker, J. J. M., Peen, J., Bosmans, J., Arntz, A., & Huibers, M. J. H. (2023) · Trials · doi:10.1186/s13063-023-07136-z · Cited by 9 · see citing works
“The Dutch norm scores will be used for calculating the mean EQ-5D utility values [99].”
MethodEndhoven, B., De Cort, K., Matthijssen, S. J. M. A., de Jongh, A., van Minnen, A., Duits, P., Schruers, K. R. J., van Dis, E. A. M., Krypotos, A. M., Gerritsen, L., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-022-04320-4 · Cited by 4 · see citing works
“ASI Anxiety Sensitivity Index ATPTM Attitudes Toward Psychotherapy Treatment Manuals BSQ Bodily Sensation Questionnaire CBT Cognitive behavioral therapy CEQ Dutch credibility and expectancy scale CS Credibility Scale CSQ-8 Client Satisfaction Questionnaire EBPAS Evidence-Based Practice Attitude Scale EMDR Eye movement…”
MethodInfluentialRemeeus, M. G. A., Clarke, S. L., Feenstra, D. J., Van Eeren, H., Smits, M. L., Debruyne, S., Kouijzer, M. E. J., Luyten, P., Scholte, R. H. J., & Hutsebaut, J. (2024) · Trials · doi:10.1186/s13063-024-08095-9 · Cited by 3 · see citing works
Bockting, C., Bosmans, G., Bergers, N., Gavan, L., Hiligsmann, M., de Beurs, D., Molenberghs, G., Wijnen, B., Lokkerbol, J., & van der Spek, N. (2024) · Trials · doi:10.1186/s13063-024-08499-7 · Cited by 1 · see citing works
- Authors
- M. Versteegh, M., M. Vermeulen, K., M. A. A. Evers, S., de Wit, G. A., Prenger, R., & A. Stolk, E.
- Affiliations
- University of Twente (NL)
- ORCID
- Prenger, Rilana
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 19
- Issue
- 4
- Pages
- 343-352
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2334353679
- Cited by
- 1,113
- References
- 26
- Citations by year
- 2026: 100 · 2025: 143 · 2024: 175 · 2023: 126 · 2022: 157 · 2021: 139 · 2020: 95 · 2019: 66 · 2018: 62 · 2017: 36 · 2016: 13
- FWCI
- 115.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Value in Health (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- University of Twente Research Information (publishedVersion, cc-by-nc-nd)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, cc-by-nc-nd)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc-nd)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Rivm (National Institute for Public Health and the Environment) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- University of Twente Research Information (submittedVersion, cc-by-nc-nd)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
- Social Sciences › Sociology and Political Science › Delphi Technique in Research
- Keywords
- EQ-5D-5L, tariffs, health state valuation, composite time trade-off, discrete choice experiment, Tobit model, health-related quality of life, economic evaluation
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Algorithms, Female, Health Status Indicators, Humans, Interviews as Topic, Male, Middle Aged, Netherlands, Quality of Life, Surveys and Questionnaires, Regression Analysis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review